Primary cutaneous follicle centre lymphoma pathophysiology
Primary cutaneous follicle centre lymphoma Microchapters |
Differentiating Primary cutaneous follicle centre lymphoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Primary cutaneous follicle centre lymphoma pathophysiology On the Web |
American Roentgen Ray Society Images of Primary cutaneous follicle centre lymphoma pathophysiology |
FDA on Primary cutaneous follicle centre lymphoma pathophysiology |
CDC on Primary cutaneous follicle centre lymphoma pathophysiology |
Primary cutaneous follicle centre lymphoma pathophysiology in the news |
Blogs on Primary cutaneous follicle centre lymphoma pathophysiology |
Directions to Hospitals Treating Splenic marginal zone lymphoma |
Risk calculators and risk factors for Primary cutaneous follicle centre lymphoma pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
Pathophysiology
Gross Pathology
-
Multinodular mass on the scalp (A) and spectacular response after the second chemotherapy course (B).[1]
Microscopic Pathology
-
Histopatological fingings. Biopsy of the mass of the scalp showing a dense and diffuse dermal infiltrate with nodular growth pattern (A) consisted of large atypical lymphocytes (H&E) (B), which are positive for CD20 (C) and Bcl6 (D) and negative for Bcl2 (E) on immunohistochemical staining. Bone marrow biopsy showing a hypercellular bone marrow with proliferation of megakaryocytes with hyperlobulated nuclei, sometimes in loose clusters (H&E) (F), positive for CD61 on immunohistochemical staining (G).[1]
References
- ↑ 1.0 1.1 Primary cutaneous follicle centre lymphoma. BioMed Central. https://biomarkerres.biomedcentral.com/articles/10.1186/2050-7771-2-7. Accessed on March 01, 2016